Webinar: FDA Drug Topics: CURE ID: Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies in the Era of COVID-19
This new webinar from the Center for Drug Evaluation (CDER), Division of Drug Information (DDI) is now available at:
The webinar is a demonstration of the CURE ID mobile app and web platform, developed by the U.S. Food and Drug Administration (FDA), in collaboration with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). CURE ID gives the global clinical community the opportunity to report novel uses of existing drugs for patients with difficult to treat infectious diseases, including COVID-19. C-Path’s CURE Drug Repurposing Collaboratory (CDRC) is working directly with the FDA and NCATS/NIH on this initiative.